| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
|
Martínez-Laperche, Carolina
|
|
|
2 |
14 |
p. 1719-1737
|
article
|
| 2 |
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances
|
Chan, Noel C.
|
|
|
2 |
14 |
p. 1806
|
article
|
| 3 |
A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML
|
Gopal, Srila
|
|
|
2 |
14 |
p. 1680-1684
|
article
|
| 4 |
CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia
|
Jiang, Ying-Ping
|
|
|
2 |
14 |
p. 1738-1749
|
article
|
| 5 |
Editorial Board
|
|
|
|
2 |
14 |
p. i
|
article
|
| 6 |
Gene therapy in hemophilia A: a cost-effectiveness analysis
|
Machin, Nicoletta
|
|
|
2 |
14 |
p. 1792-1798
|
article
|
| 7 |
HLA-DRB1–factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study
|
Kempton, Christine L.
|
|
|
2 |
14 |
p. 1750-1755
|
article
|
| 8 |
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance
|
Arrieta-Bolaños, Esteban
|
|
|
2 |
14 |
p. 1773-1783
|
article
|
| 9 |
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
|
Byrd, John C.
|
|
|
2 |
14 |
p. 1705-1718
|
article
|
| 10 |
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial
|
Cardenas, Jessica C.
|
|
|
2 |
14 |
p. 1696-1704
|
article
|
| 11 |
Prediction of cardiovascular disease among hematopoietic cell transplantation survivors
|
Armenian, Saro H.
|
|
|
2 |
14 |
p. 1756-1764
|
article
|
| 12 |
Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient
|
Zhang, Jian-Ping
|
|
|
2 |
14 |
p. 1691-1695
|
article
|
| 13 |
Significant gynecological bleeding in women with low von Willebrand factor levels
|
Lavin, Michelle
|
|
|
2 |
14 |
p. 1784-1791
|
article
|
| 14 |
TCF1 expression marks self-renewing human CD8+ T cells
|
Kratchmarov, Radomir
|
|
|
2 |
14 |
p. 1685-1690
|
article
|
| 15 |
The case against catheter-directed thrombolysis in patients with proximal deep vein thrombosis
|
Poston, Jacqueline N.
|
|
|
2 |
14 |
p. 1803-1805
|
article
|
| 16 |
The case for catheter-directed thrombolysis in selected patients with acute proximal deep vein thrombosis
|
Chiasakul, Thita
|
|
|
2 |
14 |
p. 1799-1802
|
article
|
| 17 |
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
|
Stahl, Maximilian
|
|
|
2 |
14 |
p. 1765-1772
|
article
|
| 18 |
TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine
|
Ho, Derek Hoi-Hang
|
|
|
2 |
14 |
p. 1664-1679
|
article
|
Journal description